{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T20:19:59Z","timestamp":1775420399421,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:00:00Z","timestamp":1454025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Scientific Foundation of China","doi-asserted-by":"crossref","award":["81272467"],"award-info":[{"award-number":["81272467"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Scientific Foundation of China","doi-asserted-by":"crossref","award":["81472321"],"award-info":[{"award-number":["81472321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Natural Scientific Research Foundation","award":["BS2015YY024"],"award-info":[{"award-number":["BS2015YY024"]}]},{"name":"Shandong Provincial Scientific and Technology Development Program","award":["2014GGH218039"],"award-info":[{"award-number":["2014GGH218039"]}]},{"name":"Heilongjiang Provincial Scientific Fund for Youths","award":["QC2011C089"],"award-info":[{"award-number":["QC2011C089"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00432-016-2121-8","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T05:23:54Z","timestamp":1454045034000},"page":"969-980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122"],"prefix":"10.1007","volume":"142","author":[{"given":"Huaqiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","volume":"62","author":"S Bandiera","year":"2015","unstructured":"Bandiera S, Pfeffer S, Baumert TF, Zeisel MB (2015) miR-122\u2014a key factor and therapeutic target in liver disease. J Hepatol 62:448\u2013457. doi: 10.1016\/j.jhep.2014.10.004","journal-title":"J Hepatol"},{"key":"2121_CR2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8:512\u2013522. doi: 10.1038\/nrgastro.2011.131","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2121_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","volume":"20","author":"D Bourboulia","year":"2010","unstructured":"Bourboulia D, Stetler-Stevenson WG (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20:161\u2013168. doi: 10.1016\/j.semcancer.2010.05.002","journal-title":"Semin Cancer Biol"},{"key":"2121_CR4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268\u20131289. doi: 10.1016\/j.jhep.2014.01.021","journal-title":"J Hepatol"},{"key":"2121_CR5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hep.22160","volume":"47","author":"A Budhu","year":"2008","unstructured":"Budhu A et al (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47:897\u2013907. doi: 10.1002\/hep.22160","journal-title":"Hepatology"},{"key":"2121_CR6","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","volume":"28","author":"C Coulouarn","year":"2009","unstructured":"Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28:3526\u20133536. doi: 10.1038\/onc.2009.211","journal-title":"Oncogene"},{"key":"2121_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/liv.12239","volume":"34","author":"XG Deng","year":"2014","unstructured":"Deng XG et al (2014) Overexpression of miR-122 promotes the hepatic differentiation and maturation of mouse ESCs through a miR-122\/FoxA1\/HNF4a-positive feedback loop. Liver Int 34:281\u2013295. doi: 10.1111\/liv.12239","journal-title":"Liver Int"},{"key":"2121_CR8","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","volume":"67","author":"L Gramantieri","year":"2007","unstructured":"Gramantieri L et al (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67:6092\u20136099. doi: 10.1158\/0008-5472.can-06-4607","journal-title":"Cancer Res"},{"key":"2121_CR9","doi-asserted-by":"crossref","first-page":"28867","DOI":"10.18632\/oncotarget.4814","volume":"6","author":"C He","year":"2015","unstructured":"He C et al (2015a) MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN\/Akt pathway. Oncotarget 6:28867\u201328881. doi: 10.18632\/oncotarget.4814","journal-title":"Oncotarget"},{"key":"2121_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-015-0427-9","volume":"14","author":"J He","year":"2015","unstructured":"He J et al (2015b) Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol Cancer 14:163. doi: 10.1186\/s12943-015-0427-9","journal-title":"Mol Cancer"},{"key":"2121_CR11","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"SH Hsu","year":"2012","unstructured":"Hsu SH et al (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Investig 122:2871\u20132883. doi: 10.1172\/jci63539","journal-title":"J Clin Investig"},{"key":"2121_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mc.21864","volume":"52","author":"A Karakatsanis","year":"2013","unstructured":"Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52:297\u2013303. doi: 10.1002\/mc.21864","journal-title":"Mol Carcinog"},{"key":"2121_CR13","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1101\/gad.390906","volume":"20","author":"I Kyrmizi","year":"2006","unstructured":"Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I (2006) Plasticity and expanding complexity of the hepatic transcription factor network during liver Dev. Genes Development 20:2293\u20132305. doi: 10.1101\/gad.390906","journal-title":"Genes Development"},{"key":"2121_CR14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf P et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401\u20131414. doi: 10.1016\/j.cell.2007.04.040","journal-title":"Cell"},{"key":"2121_CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2011.09.001","volume":"142","author":"I Laudadio","year":"2012","unstructured":"Laudadio I et al (2012) A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology 142:119\u2013129. doi: 10.1053\/j.gastro.2011.09.001","journal-title":"Gastroenterology"},{"key":"2121_CR16","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1096\/fj.06-6575com","volume":"21","author":"F Lehner","year":"2007","unstructured":"Lehner F, Kulik U, Klempnauer J, Borlak J (2007) The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases. FASEB J 21:1445\u20131462. doi: 10.1096\/fj.06-6575com","journal-title":"FASEB J"},{"key":"2121_CR17","doi-asserted-by":"crossref","first-page":"e13344","DOI":"10.1371\/journal.pone.0013344","volume":"5","author":"F Lehner","year":"2010","unstructured":"Lehner F, Kulik U, Klempnauer J, Borlak J (2010) Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells. PLoS ONE 5:e13344. doi: 10.1371\/journal.pone.0013344","journal-title":"PLoS ONE"},{"key":"2121_CR18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/cbt.9.7.11267","volume":"9","author":"L Ma","year":"2010","unstructured":"Ma L et al (2010) Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9:554\u2013561","journal-title":"Cancer Biol Ther"},{"key":"2121_CR19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483\u20131487. doi: 10.1126\/science.1094291","journal-title":"Science"},{"key":"2121_CR20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(01)00597-9","volume":"107","author":"J Oh","year":"2001","unstructured":"Oh J et al (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107:789\u2013800","journal-title":"Cell"},{"key":"2121_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/labinvest.2014.47","volume":"94","author":"KR Pekala","year":"2014","unstructured":"Pekala KR et al (2014) Loss of HNF6 expression correlates with human pancreatic cancer progression. Lab Investig 94:517\u2013527. doi: 10.1038\/labinvest.2014.47","journal-title":"Lab Investig"},{"key":"2121_CR22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2133\/dmpk.DMPK-12-RG-132","volume":"28","author":"T Sasaki","year":"2013","unstructured":"Sasaki T et al (2013) Hepatocyte nuclear factor 6 activates the transcription of CYP3A4 in hepatocyte-like cells differentiated from human induced pluripotent stem cells. Drug Metab Pharmacokinet 28:250\u2013259","journal-title":"Drug Metab Pharmacokinet"},{"key":"2121_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/febs.12577","volume":"281","author":"XP Sun","year":"2014","unstructured":"Sun XP et al (2014) Up-regulation of survivin by AKT and hypoxia-inducible factor 1alpha contributes to cisplatin resistance in gastric cancer. FEBS J 281:115\u2013128. doi: 10.1111\/febs.12577","journal-title":"FEBS J"},{"key":"2121_CR24","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.22806","volume":"49","author":"WC Tsai","year":"2009","unstructured":"Tsai WC et al (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49:1571\u20131582. doi: 10.1002\/hep.22806","journal-title":"Hepatology"},{"key":"2121_CR25","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","volume":"122","author":"WC Tsai","year":"2012","unstructured":"Tsai WC et al (2012) MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Investig 122:2884\u20132897. doi: 10.1172\/jci63455","journal-title":"J Clin Investig"},{"key":"2121_CR26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273\u20131281. doi: 10.1056\/NEJMoa0908721","journal-title":"N Engl J Med"},{"key":"2121_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2011.08.009","volume":"24","author":"K Wang","year":"2012","unstructured":"Wang K, Holterman AX (2012) Pathophysiologic role of hepatocyte nuclear factor 6. Cell Signal 24:9\u201316. doi: 10.1016\/j.cellsig.2011.08.009","journal-title":"Cell Signal"},{"key":"2121_CR28","doi-asserted-by":"crossref","first-page":"e47053","DOI":"10.1371\/journal.pone.0047053","volume":"7","author":"B Wang","year":"2012","unstructured":"Wang B, Wang H, Yang Z (2012) MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS ONE 7:e47053. doi: 10.1371\/journal.pone.0047053","journal-title":"PLoS ONE"},{"key":"2121_CR29","doi-asserted-by":"crossref","first-page":"e101330","DOI":"10.1371\/journal.pone.0101330","volume":"9","author":"SC Wang","year":"2014","unstructured":"Wang SC et al (2014) MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLoS ONE 9:e101330. doi: 10.1371\/journal.pone.0101330","journal-title":"PLoS ONE"},{"key":"2121_CR30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cellsig.2013.01.011","volume":"25","author":"Z Wei","year":"2013","unstructured":"Wei Z et al (2013) STAT3 interacts with Skp2\/p27\/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cell Signal 25:931\u2013938. doi: 10.1016\/j.cellsig.2013.01.011","journal-title":"Cell Signal"},{"key":"2121_CR31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/jbc.M114.601203","volume":"290","author":"Q Wu","year":"2015","unstructured":"Wu Q et al (2015) Decreased expression of hepatocyte nuclear factor 4alpha (Hnf4alpha)\/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity. J Biol Chem 290:1170\u20131185. doi: 10.1074\/jbc.M114.601203","journal-title":"J Biol Chem"},{"key":"2121_CR32","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.23818","volume":"52","author":"H Xu","year":"2010","unstructured":"Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, Qu LH (2010) Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52:1431\u20131442. doi: 10.1002\/hep.23818","journal-title":"Hepatology"},{"key":"2121_CR33","doi-asserted-by":"crossref","first-page":"31206","DOI":"10.1074\/jbc.M113.480285","volume":"288","author":"XW Yuan","year":"2013","unstructured":"Yuan XW, Wang DM, Hu Y, Tang YN, Shi WW, Guo XJ, Song JG (2013) Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition. J Biol Chem 288:31206\u201331216. doi: 10.1074\/jbc.M113.480285","journal-title":"J Biol Chem"},{"key":"2121_CR34","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.23875","volume":"52","author":"C Zeng","year":"2010","unstructured":"Zeng C et al (2010) A novel GSK-3 beta-C\/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52:1702\u20131712. doi: 10.1002\/hep.23875","journal-title":"Hepatology"},{"key":"2121_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-014-2228-7","volume":"400","author":"X Zhao","year":"2015","unstructured":"Zhao X, Liu M, Li D (2015) Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122\/Cyclin G1\/MEF2D axis. Mol Cell Biochem 400:1\u20137. doi: 10.1007\/s11010-014-2228-7","journal-title":"Mol Cell Biochem"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2121-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2121-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T15:30:28Z","timestamp":1600097428000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2121-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2121-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}